Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
Clinical trial NCT05223699 · TERMINATED
Trial details
- NCT number
- NCT05223699
- Sponsor
- Magenta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2023-02-02
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.